An investigation of the antiplatelet effects of succinobucol (AGI-1067)
Open Access
- 29 September 2016
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 28 (3) , 295-300
Abstract
Succinobucol is a phenolic antioxidant with anti-inflammatory and antiplatelet effects. Given the importance of oxidant stress in modulating platelet–platelet and platelet–vessel wall interactions, the aim of this study was to establish if antioxidant activity was responsible for the antiplatelet activity of succinobucol. Platelet aggregation in response to collagen and adenosine diphosphate (ADP) was studied in rabbit whole blood and platelet-rich plasma using impedance aggregometry. The effect of oxidant stress on aggregation, platelet lipid peroxides, and vascular tone was studied by incubating platelets, washed platelets or preconstricted rabbit iliac artery rings respectively with a combination of xanthine and xanthine oxidase (X/XO). To study the effect of succinobucol in vivo, anaesthetized rats were injected with up to 150 mg/kg succinobucol and aggregation measured in blood removed 15 mins later. Succinobucol (10−5–10−4 M) significantly attenuated platelet aggregation to collagen and ADP in whole blood and platelet-rich plasma. X/XO significantly increased aggregation to collagen and platelet lipid peroxides and this was reversed by succinobucol. Addition of X/XO to denuded rabbit iliac arteries caused a dose-dependent relaxation which was significantly inhibited by succinobucol. In vivo administration up to 150 mg/kg had no effect on heart rate or mean arterial blood pressure but significantly inhibited platelet aggregation to collagen ex vivo. In conclusion, succinobucol displays anti-platelet activity in rabbit and rat blood and reverses the increase in platelet aggregation in response to oxidant stress.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/H020675/1)
This publication has 35 references indexed in Scilit:
- The effect of reactive oxygen species on whole blood aggregation and the endothelial cell-platelet interaction in patients with coronary heart diseaseThrombosis Research, 2012
- Succinobucol‐eluting stents increase neointimal thickening and peri‐strut inflammation in a porcine coronary modelCatheterization and Cardiovascular Interventions, 2012
- H2O2-Induced Dilation in Human Coronary Arterioles: Role of Protein Kinase G Dimerization and Large-Conductance Ca2+-Activated K+Channel ActivationCirculation Research, 2012
- Succinobucol’s New Coat — Conjugation with Steroids to Alter Its Drug Effect and BioavailabilityMolecules, 2011
- Succinobucol: review of the metabolic, antiplatelet and cardiovascular effectsExpert Opinion on Investigational Drugs, 2009
- Vascular stiffness is related to superoxide generation in the vessel wallJournal Of Hypertension, 2008
- The Effect of Hydrogen Peroxide in Human Internal Thoracic Arteries: Role of Potassium Channels, Nitric Oxide and Cyclooxygenase ProductsCardiovascular Drugs and Therapy, 2007
- The In Vitro Effects of a Novel Vascular Protectant, AGI-1067, on Platelet Aggregation and Major Receptor Expression in Subjects With Multiple Risk Factors for Vascular DiseaseJournal of Cardiovascular Pharmacology and Therapeutics, 2006
- Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetesAtherosclerosis, 2004
- Effect of hematocrit on adenosine diphosphate-induced aggregation of human platelets in tube flowBiorheology, 1995